prof. xavier monnet medical intensive care unit bicêtre hospital assistance publique – hôpitaux...
TRANSCRIPT
![Page 1: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/1.jpg)
Prof. Xavier MONNET
Medical Intensive Care UnitBicêtre Hospital
Assistance publique – Hôpitaux de ParisFRANCE
Assessment of fluid therapy
Use the right tool for the right job!
![Page 2: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/2.jpg)
Conflict of interest
Pulsion Medical Systems
![Page 3: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/3.jpg)
Prof. Xavier MONNET
Medical Intensive Care UnitBicêtre Hospital
Assistance publique – Hôpitaux de ParisFRANCE
Assessment of fluid therapy
Use the right tool for the right job!
![Page 4: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/4.jpg)
APCVP
PiCCO
EsophagealDoppler
Echo
ProAQT/PulsioFlex
PAC
FloTrac/Vigileo
Nexfin
Differents monitoring devicesDifferent indications ?
![Page 5: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/5.jpg)
![Page 6: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/6.jpg)
Peri-op monitoring
ICU monitoring
Peri-
op m
onito
ring
![Page 7: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/7.jpg)
Context
Goals of monitoring
Improves prognosis
to detect hemodynamic deterioration
to guide volume expansion
High-risk surgical patients (except cardiac surgery)
Peri-
op m
onito
ring
![Page 8: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/8.jpg)
60 patients hip replacement
hospital length of stay
100 high-risksurgical patients
hospital length of stay
174 patients post cardiac surgery
hospital length of stay
162 multiple trauma patientsafter surgery
hospital length of stay ICU length of stay lactate levelPe
ri-op
mon
itorin
g Improves prognosis with esophageal Doppler
![Page 9: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/9.jpg)
60-risk general surgical patientsGoal directed therapy vs. conventional treatmentPost-operative phase
Peri-
op m
onito
ring
number of complications hospital length of stay
120 high-risk abdominalsurgery patientsSVV-directed therapy vs. conventional treatmentPer-operative phaseLidCO monitoring
number of complications hospital length of stay
Improves prognosis with LidCO
![Page 10: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/10.jpg)
40 patients with hip replacement under regional anesthesiaGoal directed therapy vs. conventional treatment
Peri-
op m
onito
ring
number of complications
Improves prognosis with Flotrac/Vigileo
![Page 11: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/11.jpg)
Vigileo Eso Doppler
preloaddependance
(Δ aortic blood flow)
preload(FTc)
Pulsioflex
preloaddependance
(VVE and Δ PP)
preloaddependance
(VVE and Δ PP)
LidCOrapid
preloaddependance
(VVE and Δ PP)
continuouscardiac output
continuouscardiac output(cardiac output)(AP curve
analysis)
continuouscardiac output(AP curve analysis)
continuouscardiac output(AP curve analysis)
Peri-
op m
onito
ring
![Page 12: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/12.jpg)
Arterial pressure
Esophageal Doppler
Flotrac/VigileoPulsioflex
LidCOrapid
PA catheter
CVP
PiCCOEV 1000
ICU monitoringOR monitoring
Basic monitoring Advanced monitoring
![Page 13: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/13.jpg)
Context
Objectives of monitoring
initial phase of shock
after the ER
assess the hemodynamic profile (type of shock)
guide initial therapy
fix some therapeutic goals
Which basic monitoring?Basi
c IC
U m
onito
ring
![Page 14: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/14.jpg)
Basi
c IC
U m
onito
ring
![Page 15: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/15.jpg)
Helps for :Helps for:
determining the type of shock(preload)
guiding fluid responsiveness(preload)
CVP Arterial pressure
deciding to give vasopressors
deciding to give fluid(if ventilated)
fixing some therapeutic goals
Basi
c IC
U m
onito
ring
DAP
PPV
MAP
![Page 16: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/16.jpg)
Arterial pressure
Esophageal Doppler
Flotrac/VigileoPulsioflex
LidCOrapid
PA catheter
CVP
PiCCOEV 1000
ICU monitoring
OR monitoring
Basic monitoring Advanced monitoring
?
?
![Page 17: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/17.jpg)
The only arterial pressure and CVP monitoring is not sufficient anymore
critically ill patients
Context
because patients receive vasopressors
Adva
nced
ICU
mon
itorin
g
when shock persists after initial fluid therapy
![Page 18: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/18.jpg)
r = 0.56n = 228
r = 0.21n = 145
*
-50 0 50 100 150 200 250 300-50
0
50
100
150
200
250
300
Changes in CI induced by VE (%)
Changes in PPinduced by VE (%)
-50 0 50 100 150 200 250 300-50
0
50
100
150
200
250
300
Changes in CI induced by NE (%)
Changes in PPinduced by NE (%)
228 pts receiving volume expansion145 patients with increase of NE
Adva
nced
ICU
mon
itorin
g
![Page 19: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/19.jpg)
-20
0
20
40
60
80
100
non responders responders
changes in CI (%)
-20
0
20
40
60
80
100
non responders responders
changes in PP (%)
+15%
6% false +
228 pts receiving volume expansion145 patients with increase of NE
22% false -
Adva
nced
ICU
mon
itorin
g
![Page 20: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/20.jpg)
Adva
nced
ICU
mon
itorin
gVigileo Eso Doppler
preloaddependance
(Δ aortic blood flow)
preload(FTc)
Pulsioflex
preloaddependance
(VVE and Δ PP)
preloaddependance
(VVE and Δ PP)
LidCOrapid
preloaddependance
(VVE and Δ PP)
continuouscardiac output
continuouscardiac output(cardiac output)(AP curve
analysis)
continuouscardiac output(AP curve analysis)
continuouscardiac output(AP curve analysis)
continuouscardiac output
AP curve analysis
uncalibrated
continuouscardiac output
AP curve analysis
uncalibrated
continuouscardiac output
AP curveanalysis
uncalibrated
![Page 21: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/21.jpg)
20
40
60
80
100
120
0
= k . SV
Uncalibrated devices
estimate SV from the arterial pressure curve
estimate arterial compliance by analysing the arterial waveform
?still valuable when the properties of the arterial curve
change in a large extent (sepsis, vasopressors)
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 22: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/22.jpg)
3.5 L/min
PiCCO and EV1000 devices measure cardiac output by
arterial pressure curveanalysis
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 23: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/23.jpg)
PiCCO and EV1000 devices measure cardiac output by
inj
Blood temperature (Ts)
Ttm
cold bolus
calibrated by
transpulmonarythermodilution
arterial pressure curveanalysis
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 24: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/24.jpg)
Vigileo2
PiCCO
calibratedcardiac index
uncalibratedcardiac index
changes induced byvolume expansion (40 patients)
changes induced bynorepinephrine (40 patients)
Ability to track
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 25: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/25.jpg)
-15 0 15 30 45 60 75
-15
0
15
30
45
60
75
D CItd (%)
r = 0.78p < 0.05
PiCCO
r = -0.03p = NS
-15 0 15 30 45 60 75 90 105 120
-15
0
15
30
45
60
75
90
105
120
D CItd (%)
Vigileo2
Changes induced by
norepinephrine
Changes induced by
volume expansion
PiCCO
r = 0.72p < 0.05
-15 0 15 30 45 60 75 90 105 120
-15
0
15
30
45
60
75
90
105
120
DC
Ipc
(%)
DCItd (%)
Vigileo2
r = 0.33p < 0.05
-15 0 15 30 45 60 75 90 105 120
-15
0
15
30
45
60
75
90
105
120
DC
Ipw
(%
)
D CItd (%)
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 26: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/26.jpg)
51 pts, 401 measurementsVigileo2 vs.Vigileo3 vs. PAC
Vigileo3 is more accurate and as precise than Vigileo2
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 27: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/27.jpg)
33 patientsVigileo3 vs. esophageal DopplerHemodynamic challenges by phenylephrine, ephedrine and whole-body tilting
Which device for advanced monitoring?Ad
vanc
ed IC
U m
onito
ring
![Page 28: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/28.jpg)
PA catheter
Which device for monitoring cardiac output?
PiCCO EV 1000
cardiac output cardiac output cardiac output
Adva
nced
ICU
mon
itorin
g
![Page 29: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/29.jpg)
Context
Goals of monitoring
predict fluid responsiveness
precisely monitor the effects of therapy
fix some therapeutic goals
when shock persists after initial fluid therapy
assess the risk of fluid expansion
critically ill patients
Adva
nced
ICU
mon
itorin
g
![Page 30: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/30.jpg)
PA catheter PiCCO EV 1000
cardiac output cardiac output cardiac output
SvO2ScvO2 ScvO2
How to assess the need for fluid?Ad
vanc
ed IC
U m
onito
ring
![Page 31: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/31.jpg)
Context
Goals of monitoring
predict fluid responsiveness
precisely monitor the effects of therapy
fix some therapeutic goals
when shock persists after initial fluid therapy
assess the risk of fluid expansion
critically ill patients
Adva
nced
ICU
mon
itorin
g
![Page 32: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/32.jpg)
PA catheter PiCCO EV 1000
cardiac output cardiac output cardiac output
PAOP
SvO2ScvO2 ScvO2
How to assess the need for fluid?
PPV, SVV,PLR test, EEO test
PPV, SVV,PLR test, EEO test
Adva
nced
ICU
mon
itorin
g
![Page 33: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/33.jpg)
How to assess the need for fluid?Ad
vanc
ed IC
U m
onito
ring
![Page 34: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/34.jpg)
EV 1000PA catheter PiCCO
cardiac output cardiac output cardiac output
PAOP
SvO2ScvO2 ScvO2
How to assess the need for fluid?
PPV, SVV,PLR test, EEO test
PPV, SVV,PLR test, EEO test
continuous continuous
Adva
nced
ICU
mon
itorin
g
![Page 35: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/35.jpg)
venous return
How to assess the need for fluid?Ad
vanc
ed IC
U m
onito
ring
![Page 36: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/36.jpg)
34 patients with acute circulatory failure
monitored by PiCCO device
-10
0
10
20
30
40
50
Effects of end-expiratory pause
on cardiac index
increase 5%Se = 91%Sp = 100 %
How to assess the need for fluid?Ad
vanc
ed IC
U m
onito
ring
RNR
![Page 37: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/37.jpg)
How to assess the need for fluid?Ad
vanc
ed IC
U m
onito
ring
![Page 38: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/38.jpg)
Context
Goals of monitoring
predict fluid responsiveness
precisely monitor the effects of therapy
fix some therapeutic goals
when shock persists after initial fluid therapy
assess the risk of fluid expansion
critically ill patients
Adva
nced
ICU
mon
itorin
g
![Page 39: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/39.jpg)
EV 1000PA catheter PiCCO
cardiac output cardiac output cardiac output
PAOP
SvO2ScvO2 ScvO2
PPV, SVV,PLR test, EEO test
PPV, SVV,PLR test, EEO test
lung waterand lung permeability
lung waterand lung permeability
How to assess the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 40: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/40.jpg)
Pcap
lung water
normal permeability
very high permeability
Pcap
lungwater
How to assess the risk of volume expansion?
high permeability
Adva
nced
ICU
mon
itorin
g
Lung permeability
![Page 41: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/41.jpg)
Lung water for estimating the risk of volume expansion?
Pcap
Lung water
normal permeability
very high permeability
Pcap
lungwater
lungwater
high permeability
Lung permeability
Adva
nced
ICU
mon
itorin
g
![Page 42: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/42.jpg)
Cold bolus
PiCCO EV1000
Lung water for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 43: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/43.jpg)
validation in human beings→
Lung water for estimating the risk of volume expansion?
30 ptsEVLW measured by TPTD and by postmortem gravimetry
First validation of EVLW-TPTD evaluation in humans
Adva
nced
ICU
mon
itorin
g
![Page 44: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/44.jpg)
Lung water for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 45: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/45.jpg)
Extra-vascular lung water and pulmonary vascular permeability index are independent prognostic factors in patients with acute respiratory distress syndrome
Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X
0
20
40
60
80
100
EVLWImax > 21 mL/kg EVLWImax ≤ 21 mL/kg
70%
42%
p = 0.0001
Day-28 mortality (%)
p value
Maximal blood lactate 0.81 (0.71 - 0.93) 0.002
Mean PEEP 1.25 (1.07 - 1.47) 0.005
EVLWI max 0.94 (0.87 - 0.98) 0.01
SAPS II 0.97 (0.95 - 0.99) 0.02
Mean fluid balance 0.9996 ( 0.9993 - 0.9999) 0.02
Minimal P/F ratio 1.01 (1.00 - 1.02) 0.02
Minimal pH 35.97 (0.47 - 2769.52) 0.10
Odds Ratio ( CI 95%)
200 pts with ARDS
EVLW measured by PiCCO device
Lung water for estimating the risk of volume expansion?
submitted
Adva
nced
ICU
mon
itorin
g
![Page 46: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/46.jpg)
PAOP group
EVLW group
Time (hours)
Cumulative fluid balance (input - output; L)
7
3
1
5
-1
-3
-5
0 12 24 36 48 60 72
***
*
* p < 0.0001 vs time 0
Mitchell JP et al., Am Rev Respir Dis 1992
101 ARDS patients
randomized to EVLW-guided management vs.
PAOP-guided management
Lung water for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 47: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/47.jpg)
0
5
10
15
20
25
Ventilation days ICU days
PAOP Group
EVLW Group
** Management of
fluid therapy with :
functional benefit of lung water monitoring
Mitchell JP et al., Am Rev Respir Dis 1992
101 ARDS patients
randomized to EVLW-guided management vs.
PAOP-guided management
Lung water for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 48: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/48.jpg)
Lung water for estimating the risk of volume expansion
Pcap
Lung water
normal permeability
very high permeability
Pcap
lungwater
lungwater
high permeability
Lung permeability
Adva
nced
ICU
mon
itorin
g
![Page 49: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/49.jpg)
lung water
cold bolus pulmonary blood volume
pulmonary vascularpermeability index =PVPI
PiCCO EV1000
Lung permeability for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 50: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/50.jpg)
0123456789
10PVPI
ALI/ARDS Hydrostaticpulmonary edema
*
Cut-off : 3
Se = 85 %
Sp = 100 %
48 patients with pulmonary edema
inflammatory vs. hydrostatic discriminated by experts
PVPI by the PiCCO device
Lung permeability for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 51: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/51.jpg)
PVPI = 4 PVPI= 7
ARDS
AP = 90 / 40 mmHg
Cardiac index = 2.0 L/min/m2
PaO2/FiO2 = 180 mmHg
PLR test : positive
ARDS
AP = 90 / 40 mmHg
Cardiac index = 2.0 L/min/m2
PaO2/FiO2 = 180 mmHg
PLR test : positive
volume expansion volume expansion
vasopressors?
Lung permeability for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 52: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/52.jpg)
PA catheter PiCCO EV 1000
cardiac output cardiac output cardiac output
PAOP
SvO2ScvO2 ScvO2
PPV, VVE,PLR test, EEO test
PPV, VVE,PLR test, EEO test
lung waterand lung permeability
lung waterand lung permeability
Lung permeability for estimating the risk of volume expansion?Ad
vanc
ed IC
U m
onito
ring
![Page 53: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/53.jpg)
APCVP
PiCCO
EsophagealDoppler
Echo
ProAQT/PulsioFlex
PAC
FloTrac/vigileo
Nexfin
Differents monitoring devicesDifferent indications !
![Page 54: Prof. Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique – Hôpitaux de Paris FRANCE Assessment of fluid therapy Use the right](https://reader035.vdocuments.us/reader035/viewer/2022062517/56649efe5503460f94c1281f/html5/thumbnails/54.jpg)
Arterial pressure
Esophageal Doppler
Flotrac/VigileoPulsioflex
LidCOrapid
PA catheter
CVP
PiCCOEV 1000
ICU monitoring
OR monitoring
Basic monitoring Advanced monitoring